Canurta Therapeutics

Canurta Therapeutics is a Canadian biotech company advancing botanical therapeutics for inflammatory and neurodegenerative diseases. Through its proprietary PolyKye™ Platform, Canurta combines AI-powered discovery, blockchain-secured supply chains, and globally patented compounds to deliver novel treatments for conditions like ALS and Alzheimer’s. Its lead candidate, CNR-401, is progressing toward Phase 2/3 trials. Canurta holds Bitcoin on its balance sheet as part of its long-term capital strategy, aiming to build a sustainable treasury through its innovative Satoshi Trials™ initiative.